These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15665627)

  • 1. Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.
    Van Den Bossche B; D'haeninck E; Bacher K; Thierens H; Van Belle S; Dierckx RA; Van de Wiele C
    Cancer Biother Radiopharm; 2004 Dec; 19(6):776-83. PubMed ID: 15665627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.
    Van de Wiele C; Dumont F; Dierckx RA; Peers SH; Thornback JR; Slegers G; Thierens H
    J Nucl Med; 2001 Nov; 42(11):1722-7. PubMed ID: 11696645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution on Tc-99m labeled somatostatin receptor-binding peptide (Depreotide, NeoTec) planar and SPECT studies.
    Shih WJ; Hirschowitz E; Bensadoun E; Woodring J; Ryo YU; Kraman S
    Ann Nucl Med; 2002 May; 16(3):213-9. PubMed ID: 12126047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
    Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
    J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
    Rijks LJ; Busemann Sokole E; Stabin MG; de Bruin K; Janssen AG; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):40-7. PubMed ID: 9396873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
    Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
    J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.
    Herlin G; Kölbeck KG; Menzel PL; Svensson L; Aspelin P; Capitanio A; Axelsson R
    Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.
    Keleher A; Wendt R; Delpassand E; Stachowiak AM; Kuerer HM
    Breast J; 2004; 10(6):492-5. PubMed ID: 15569204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection.
    De Winter F; Van de Wiele C; Dumont F; Van Durme J; Solanki K; Britton K; Slegers G; Dierckx RA; Thierens H
    Eur J Nucl Med; 2001 May; 28(5):570-4. PubMed ID: 11383860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.
    Van Den Bossche B; D'haeninck E; De Vos F; Dierckx RA; Van Belle S; Bracke M; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1022-30. PubMed ID: 15029461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and Internal Radiation Dosimetry of
    Song YS; Kim JH; Lee BC; Jung JH; Park HS; Kim SE
    Cancer Biother Radiopharm; 2018 Nov; 33(9):396-402. PubMed ID: 30133309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and dosimetry of (iodine-123)-iodomethyl-N, N-diethyltamoxifen, an (anti)oestrogen receptor radioligand.
    Van de Wiele C; De Vos F; De Sutter J; Dumont F; Slegers G; Dierckx RA; Thierens H
    Eur J Nucl Med; 1999 Oct; 26(10):1259-64. PubMed ID: 10541823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biokinetics of (99m)Tc-UBI 29-41 in humans.
    Meléndez-Alafort L; Rodríguez-Cortés J; Ferro-Flores G; Arteaga De Murphy C; Herrera-Rodríguez R; Mitsoura E; Martínez-Duncker C
    Nucl Med Biol; 2004 Apr; 31(3):373-9. PubMed ID: 15028250
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Santos-Cuevas C; Davanzo J; Ferro-Flores G; García-Pérez FO; Ocampo-García B; Ignacio-Alvarez E; Gómez-Argumosa E; Pedraza-López M
    Nucl Med Biol; 2017 Sep; 52():1-6. PubMed ID: 28575794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD 2 in non-human primates.
    Jia B; Liu Z; Zhu Z; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
    Mol Imaging Biol; 2011 Aug; 13(4):730-6. PubMed ID: 20694579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.